Showing results (131-140 of 419) with videos related to

Sort By:
Pageof 42
ESMO Open|April 10, 2019
Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCISTKalevi Kairemo, Eric M Rohren, Pete M Anderson, et al.
ESMO Open|April 19, 2020
223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapyPete M Anderson, Jacob Scott, Shireen Parsai, et al.
Trends in Cancer|February 27, 2020
Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?Jacob J Adashek, Ishwaria M Subbiah, Ignacio Matos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2020
Progresses Toward Precision Medicine in RET-altered Solid TumorsCarmen Belli, Santosh Anand, Justin F Gainor, et al.
ESMO Open|August 21, 2020
Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitorsKartik Anand, Geetanjali Sahu, Ethan Burns, et al.
Pharmacoeconomics|October 27, 2023
Transporting Comparative Effectiveness Evidence Between Countries: Considerations for Health Technology AssessmentsAlex J Turner, Cormac Sammon, Nick Latimer, et al.
Current Problems in Cancer|October 17, 2021
Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implicationsRoberto Carmagnani Pestana, Jason Roszik, Roman Groisberg, et al.
Cancers|October 23, 2021
Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue SarcomaJason Roszik, Lisa Maria Mustachio, John A Livingston, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|July 3, 2014
Incidence and impact of adverse effects of medical care on complications in patients who underwent excision of cervical lymph nodesVeerasathpurush Allareddy, Satheesh Elangovan, Steven L Fletcher, et al.
Transplantation and Cellular Therapy|March 15, 2025
Defining the Quality Attributes for Tumor-Infiltrating Lymphocyte Medicinal ProductsJustin J Lievense, Cynthia Nijenhuis, Inge Jedema, et al.
Pageof 42